The latest closing stock price for MaxCyte as of May 19, 2025 is 2.28.
An investor who bought $1,000 worth of MaxCyte stock at the IPO in 2021 would have $-866 today, roughly -1 times their original investment - a -39.48% compound annual growth rate over 4 years.
The all-time high MaxCyte stock closing price was 17.20 on September 03, 2021.
The MaxCyte 52-week high stock price is 5.26, which is 130.7% above the current share price.
The MaxCyte 52-week low stock price is 2.10, which is 7.9% below the current share price.
The average MaxCyte stock price for the last 52 weeks is 3.85.
An investor who bought $1,000 worth of MaxCyte stock at the IPO in 2021 would have $-866 today, roughly -1 times their original investment - a -39.48% compound annual growth rate over 4 years.
The all-time high MaxCyte stock closing price was 17.20 on September 03, 2021.
The MaxCyte 52-week high stock price is 5.26, which is 130.7% above the current share price.
The MaxCyte 52-week low stock price is 2.10, which is 7.9% below the current share price.
The average MaxCyte stock price for the last 52 weeks is 3.85.